Product Information
TEKTURNA 300 MG TABLET is a brand product labeled by LXO US Inc., priced at $15.0945 per EA under NDC 70839030030. Its NADAC has been published 477 times since May 10, 2017.
Strength
300 mg/1
Manufacturer
LXO US Inc.NDC
70839030030
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
1/6/2026
Active Ingredients
ALISKIREN HEMIFUMARATEApproval Type
New Drug (NDA)
FDA Application
NDA021985On Market Since
3/5/2007
Pharmacological Classes
Price Statistics
The NADAC for TEKTURNA 300 MG TABLET has been published 477 times since May 10, 2017, and over the history we have for it it has risen 126.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $15.0945 per EA |
|---|---|
| All-time high | $15.0945 (Jun 24, 2026) |
| All-time low | $6.6303 (Jun 21, 2017) |
| 52-week high | $15.0945 |
| 52-week low | $13.8480 |
| Median price | $9.8722 |
| Average price | $10.4037 |
| Largest weekly change | +15.5% (Nov 14, 2018) |
| Weeks tracked | 477 |
| Tracking since | May 10, 2017 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 62% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of TEKTURNA 300 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for TEKTURNA 300 MG TABLET, manufactured by LXO US Inc., is $15.0945 per EA (NDC 70839030030), effective Jun 24, 2026.
How has the price of TEKTURNA 300 MG TABLET changed over time?
Over the history we have for it, the NADAC for TEKTURNA 300 MG TABLET has risen 126.3%. It has been tracked across 477 weekly CMS publications since May 10, 2017.
What are the highest and lowest recorded NADAC prices for TEKTURNA 300 MG TABLET?
Since May 10, 2017, the NADAC for TEKTURNA 300 MG TABLET has ranged from a low of $6.6303 (Jun 21, 2017) to a high of $15.0945 (Jun 24, 2026), with a median of $9.8722 per EA.
Are there cheaper alternatives to TEKTURNA 300 MG TABLET?
Yes. 1 NADAC-published product shares the same active ingredient, strength, and dosage form. The lowest-priced option, ALISKIREN 300 MG TABLET, is $5.6762 per EA — about 62% below TEKTURNA 300 MG TABLET.
Who manufactures TEKTURNA 300 MG TABLET?
TEKTURNA 300 MG TABLET (NDC 70839030030) is labeled by LXO US Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification